Weybosset Research & Management LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
Ava Hoppe | 22 July, 2023
Did Weybosset Research & Management LLC experience significant changes in their fund holdings between Q1 2023 and Q2 2023? Let's take a closer look at the data and analyze the key findings.
In Q1 2023, Weybosset Research & Management held shares in various companies, and by Q2 2023, some changes in their holdings were observed. It's fascinating to see how these alterations in positions can impact the overall value of the fund.
One of the most notable changes involved the company Copart Inc (CPRT). During this period, Weybosset Research & Management saw a decrease in their holdings, as they went from 377,211 shares in Q1 to 367,603 shares in Q2. Despite the decrease in shares, the value of their holdings increased from $28,370,000 to $33,529,000, representing substantial growth of 18.2%.
Similarly, Deere & Co (DE) experienced a slight decrease in holdings, dropping from 53,018 shares in Q1 to 52,454 shares in Q2. However, the value of their holdings decreased from $21,890,000 to $21,254,000, representing a slight decrease of 2.9%.
On the other hand, Weybosset Research & Management saw an increase in holdings for certain companies. Hexcel Corp New (HXL) witnessed an increase in shares from 185,834 to 182,949, while the value of their holdings rose from $12,683,000 to $13,908,000, indicating a growth of 9.7%.
The changes in holdings of Berkshire Hathaway Inc Del (BRK-B) were minimal. Weybosset Research & Management's holdings remained almost the same, with a slight increase from 39,896 shares in Q1 to 39,965 shares in Q2. The value of their holdings rose from $12,319,000 to $13,628,000, representing a modest growth of 10.6%.
Furthermore, significant changes were observed in the holdings of Bank OZK Little Rock Ark (OZK). Weybosset Research & Management's holdings decreased from 258,501 shares in Q1 to 257,542 shares in Q2. However, the value of their holdings experienced substantial growth, increasing from $8,841,000 to $10,343,000, representing a growth rate of 17%.
Several other companies also experienced changes in holdings, with some witnessing growth, and others experiencing a slight decrease. It is worth noting that not all changes were significant, and some changes could be attributed to regular portfolio management strategies.
It's crucial to consider that the data reflected in this comparison showcases the changes in holdings of Weybosset Research & Management LLC. As with any investment, these holdings are subject to market fluctuations and varied investment strategies.
Overall, analyzing and understanding the changes in holdings between Q1 2023 and Q2 2023 provides valuable insights into the investment decisions made by Weybosset Research & Management LLC. These changes highlight the dynamic nature of the investment landscape and the importance of monitoring and adjusting investment portfolios accordingly.
Disclaimer: The data provided in this article is based on public information. The information presented here may not be accurate or complete. Investors and readers are advised to do their own research and consult with financial professionals before making any investment decisions.
Other Posts
- Comparing Harding Loevner LP's Q3 and Q4 2022 13F Holdings: A Look at the Numbers
- EngageSmart Acquisition Investigation: Protecting Shareholder Rights in ESMT Privatization Deal
- Investing Insights: Gibraltar Capital's Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Navigating the Fluctuations: Windsor Capital Management's Strategy Shifts in Early 2024
- From Procter & Gamble to Home Depot: Comparing Bahl & Gaynor Inc's Q3 and Q4 2022 13F Holdings
- Analyzing HC Financial Advisors’ Q2 2018 vs. Q3 2018 13F Filing: Increased and Decreased Holdings
- Investing Insights: Minerva Advisors LLC Q3 2022 vs. Q4 2022 Holdings Comparison
- Hoertkorn Richard Charles Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Duff & Phelps Investment Management Co Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Urologic Consultants Joins Solaris Health: Advancing Urological Care Nationwide